83 results
POS AM
SPRC
SciSparc Ltd
17 Jun 24
Prospectus update (post-effective amendment)
4:05pm
and research and development costs are in NIS. AutoMax is therefore exposed to foreign currency risk due to fluctuations in exchange rates. This may … condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our product candidates, and all
6-K
EX-99.1
SPRC
SciSparc Ltd
3 Jun 24
SciSparc Secures Strategic Advantage with Grant of European Patent
7:13am
globally and highlights the Company’s dynamic approach to research and development. This addition marks another milestone in SciSparc’s ongoing
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
the majority of its revenues and AutoMax’s management, marketing, sales and research and development costs are in NIS. AutoMax is therefore exposed … of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
profit
Research and development expenses
Sales and marketing
Impairment of intangible asset
General and administrative expenses
Operating loss
SciSparc’s
6-K
EX-99.2
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
Ltd
AutoMax
Motors Ltd
Pro Forma
Adjustments
Pro Forma
Revenues
Cost of goods sold
Gross profit
Research and development expenses
Sales and marketing
20-F/A
i2f9flwyc5a98fvh2h
2 May 24
Annual report (foreign) (amended)
9:18am
F-1
92l6n3622vwci3td
27 Feb 24
Registration statement (foreign)
4:15pm
F-3/A
byks15dnycsb2uktkica
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
arvywaflwr
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
dwqfc4f7alj
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
EX-99.1
d3waoj83 eczql9te
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.2
2g3xb19fby361ws3
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
kbtb dipfakt628h
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
y32a3qb7rbh8os
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
d0a 2ms3iw
10 Aug 23
Prospectus supplement
6:32am
424B5
8mzy9stw
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.2
01eeh7zamxotyp9i
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
8ndd3f6se1p
29 Dec 22
Interim Consolidated Financial Statements
4:03pm